Cadamuro, M.; Sarcognato, S.; Camerotto, R.; Girardi, N.; Lasagni, A.; Zanus, G.; Cillo, U.; Gringeri, E.; Morana, G.; Strazzabosco, M.;
et al. Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma. Int. J. Mol. Sci. 2023, 24, 4748.
https://doi.org/10.3390/ijms24054748
AMA Style
Cadamuro M, Sarcognato S, Camerotto R, Girardi N, Lasagni A, Zanus G, Cillo U, Gringeri E, Morana G, Strazzabosco M,
et al. Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma. International Journal of Molecular Sciences. 2023; 24(5):4748.
https://doi.org/10.3390/ijms24054748
Chicago/Turabian Style
Cadamuro, Massimiliano, Samantha Sarcognato, Riccardo Camerotto, Noemi Girardi, Alberto Lasagni, Giacomo Zanus, Umberto Cillo, Enrico Gringeri, Giovanni Morana, Mario Strazzabosco,
and et al. 2023. "Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma" International Journal of Molecular Sciences 24, no. 5: 4748.
https://doi.org/10.3390/ijms24054748
APA Style
Cadamuro, M., Sarcognato, S., Camerotto, R., Girardi, N., Lasagni, A., Zanus, G., Cillo, U., Gringeri, E., Morana, G., Strazzabosco, M., Campello, E., Simioni, P., Guido, M., & Fabris, L.
(2023). Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma. International Journal of Molecular Sciences, 24(5), 4748.
https://doi.org/10.3390/ijms24054748
